ChartRow logo
Share this page
DFTX
$32.10-6.30%
as of close, Oct 16, 2026
☾ AH $32.10 -6.30%
Definium Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.009%Russell 3000 0.008%
PeersMRNALLYMDTUNHJNJTMO

Definium Therapeutics Inc. trailing returns

How Definium Therapeutics Inc. (DFTX) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-6.3%+0.0%-6.3%—
5 days-13.0%+0.0%-13.0%-13.0%Oct 16
1 month-15.2%+0.0%-15.2%-20.4%Oct 16
YTD+139.7%+0.0%+139.7%-33.7%Oct 16
1 year+169.5%+0.0%+169.5%-33.7%Oct 2026
5 years-1.9%+0.0%-1.9%-8.9%-95.0%Dec 2022
Since inception (2016)+25.5%+0.0%+25.5%+851.1%-99.9%Dec 2019

Growth of DFTX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-1.9%/year · -8.9%
  • Since inception (2016)+25.5%/year · +851.1%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in DFTX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Definium Therapeutics Inc.'s return since inception?
Since 2016, Definium Therapeutics Inc. (DFTX) has compounded at about +25.5% a year — +851.1% in total.

More on Definium Therapeutics Inc.